PTJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


PHYS THER
Vol. 88, No. 4, April 2008, pp. 437-448
DOI: 10.2522/ptj.20070035

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ptj.20070035v1
88/4/437    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kottink, A. I.
Right arrow Articles by IJzerman, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kottink, A. I.
Right arrow Articles by IJzerman, M. J
Related Collections
Right arrow Electrotherapy
Right arrow Motor Control and Motor Learning
Right arrow Stroke (Neurology)
Right arrow Randomized Controlled Trials
Right arrow Stroke (Geriatrics)
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Research Reports

Therapeutic Effect of an Implantable Peroneal Nerve Stimulator in Subjects With Chronic Stroke and Footdrop: A Randomized Controlled Trial

Anke IR Kottink, Hermie J Hermens, Anand V Nene, Martin J Tenniglo, Catharina G Groothuis-Oudshoorn and Maarten J IJzerman

AIR Kottink, MSc, is Human Movement Scientist, Roessingh Research and Development, PO Box 310, 7500 AH, Enschede, the Netherlands
HJ Hermens, PhD, is Clustermanager, Roessingh Research and Development, and Professor of Neuromuscular Control and Professor of Remote Monitoring and Treatment, Institute for Biomedical Technology, University of Twente, Enschede, the Netherlands
AV Nene, MD, PhD, is Senior Researcher, Roessingh Research and Development, and Rehabilitation Doctor, Roessingh Rehabilitation Center, Enschede, the Netherlands
MJ Tenniglo, PT, is Physiotherapist, Roessingh Rehabilitation Center
CG Groothuis-Oudshoorn, PhD, is Biostatistician, Roessingh Research and Development
MJ IJzerman, PT, PhD, is Chair, Clinical Epidemiology and Health Technology Assessment, Institute for Biomedical Technology, University of Twente

Address all correspondence to Ms Kottink at: a.kottink{at}rrd.nl

Background and Purpose: Footdrop, characterized by a person's inability to raise the foot at the ankle, is a common problem in patients with stroke. A randomized controlled trial was performed to determine the therapeutic effect of using a new implantable, 2-channel peroneal nerve stimulator for 6 months versus an ankle-foot orthosis (AFO).

Subjects: Twenty-nine patients with chronic stroke and footdrop participated in the study. The mean time from stroke was 7.3 years (SD=7.3), and all subjects were community ambulators.

Methods: The study used a randomized controlled trial design. The functional electrical stimulation (FES) group received the implantable stimulation system for correction of their footdrop. The control group continued using their conventional walking device (ie, AFO, orthopedic shoes, or no walking device). All subjects were measured at baseline and at weeks 4, 8, 12, and 26 in the gait laboratory. The therapeutic effect of FES on the maximum value of the root mean square (RMSmax) of the tibialis anterior (TA) muscle with both flexed and extended knees and walking speed were selected as the primary outcome measures. The RMSmax of the peroneus longus (PL), gastrocnemius (GS), and soleus (SL) muscles with both flexed and extended knees and muscle activity of the TA muscle of the affected leg during the swing phase of gait were selected as secondary outcome measures.

Results: A significantly higher RMSmax of the TA muscle with extended knee was found after using FES. No change in walking speed was found when the stimulator was not switched on. A significantly increased RMSmax of the GS muscle with both flexed and extended knees was found after using FES.

Discussion and Conclusion: Functionally, no therapeutic effect of implantable peroneal nerve stimulation was found. However, the significantly increased voluntary muscle output of the TA and GS muscles after the use of FES suggests that there was a certain extent of plasticity in the subjects in this study.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ptjournalHome page
K. Dunning, K. Black, A. Harrison, K. McBride, and S. Israel
Neuroprosthesis Peroneal Functional Electrical Stimulation in the Acute Inpatient Rehabilitation Setting: A Case Series
Physical Therapy, May 1, 2009; 89(5): 499 - 506.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Physical Therapy Association.